Literature DB >> 667839

Resistance of resting 3T6 mouse fibroblasts to methotrexate cytotoxicity.

L F Johnson, C L Fuhrman, H T Abelson.   

Abstract

We have compared the relative susceptibility of resting (GO) versus exponentially growing mouse fibroblasts (line 3T6) to methotrexate (MTX) cytotoxicity. Cultures of cells were exposed to different levels of MTX for various intervals. Cloning efficiencies of the cells were then determined in medium containing hypoxanthine and thymidine. We found that growing 3T6 cells exhibit time- as well as dose-dependent cytotoxicity. Greater than 95% of the cells were killed by a 24-hr exposure to 10(-6) M MTX. In contrast resting cells showed no loss of cloning efficiency even at drug concentrations of 10(-3) M and exposure times of 7 days. The resistance of resting cells is not the result of a MTX transport deficiency since extracellular MTX is taken up by both resting and growing cells. Furthermore, intracellular dihydrofolate reductase activity is abolished in both resting and growing cells at similar extracellular MTX dosages.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 667839

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Quantitative aspects of the selective killing of transformed cells by methotrexate in the presence of leucovorin.

Authors:  M Chow; H Rubin
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999 Jul-Aug       Impact factor: 2.416

2.  Selective killing of preneoplastic and neoplastic cells by methotrexate with leucovorin.

Authors:  M Chow; H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

3.  Molecular cloning and analysis of a cDNA coding for the bifunctional dihydrofolate reductase-thymidylate synthase of Daucus carota.

Authors:  M Luo; P Piffanelli; L Rastelli; R Cella
Journal:  Plant Mol Biol       Date:  1993-06       Impact factor: 4.076

4.  Long-duration intracavitary infusion of methotrexate with systemic leucovorin protection in patients with malignant effusions.

Authors:  S B Howell; B B Chu; W E Wung; B M Metha; J Mendelsohn
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

5.  Uptake of methotrexate linked to an anti-EL4-lymphoma antibody by EL4 cells.

Authors:  P Uadia; A H Blair; T Ghose
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

6.  Accumulation of DNA strand breaks and methotrexate cytotoxicity.

Authors:  J C Li; E Kaminskas
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

7.  Cell cycle regulation of dihydrofolate reductase mRNA metabolism in mouse fibroblasts.

Authors:  S L Hendrickson; J S Wu; L F Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

8.  Novel N-arylamide derivatives of (S)-perillic acid ((S)-PA): in vitro and in vivo cytotoxicity and antitumor evaluation.

Authors:  Yusif Mohammed Mukhtar; Kaili Wang; Ran Li; Wenwen Deng; Michael Adu-Frimpong; Huiyun Zhang; Kangyi Zhang; Chenlu Gu; Ximing Xu; Jiangnan Yu
Journal:  RSC Adv       Date:  2019-06-26       Impact factor: 4.036

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.